188 related articles for article (PubMed ID: 36232837)
1. Rho/SRF Inhibitor Modulates Mitochondrial Functions.
Patyal P; Nguyen B; Zhang X; Azhar G; Ameer FS; Verma A; Crane J; Kc G; Che Y; Wei JY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232837
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of Rho/MRTF/SRF Transcription Pathway Regulate Mitochondrial Function.
Patyal P; Zhang X; Verma A; Azhar G; Wei JY
Cells; 2024 Feb; 13(5):. PubMed ID: 38474356
[TBL] [Abstract][Full Text] [Related]
3. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.
Johnson LA; Rodansky ES; Haak AJ; Larsen SD; Neubig RR; Higgins PD
Inflamm Bowel Dis; 2014 Jan; 20(1):154-65. PubMed ID: 24280883
[TBL] [Abstract][Full Text] [Related]
4. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Evelyn CR; Wade SM; Wang Q; Wu M; Iñiguez-Lluhí JA; Merajver SD; Neubig RR
Mol Cancer Ther; 2007 Aug; 6(8):2249-60. PubMed ID: 17699722
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological intervention of MKL/SRF signaling by CCG-1423 impedes endothelial cell migration and angiogenesis.
Gau D; Veon W; Capasso TL; Bottcher R; Shroff S; Roman BL; Roy P
Angiogenesis; 2017 Nov; 20(4):663-672. PubMed ID: 28638990
[TBL] [Abstract][Full Text] [Related]
6. Serum Response Factor (SRF)-cofilin-actin signaling axis modulates mitochondrial dynamics.
Beck H; Flynn K; Lindenberg KS; Schwarz H; Bradke F; Di Giovanni S; Knöll B
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):E2523-32. PubMed ID: 22927399
[TBL] [Abstract][Full Text] [Related]
7. Redox modification of nuclear actin by MICAL-2 regulates SRF signaling.
Lundquist MR; Storaska AJ; Liu TC; Larsen SD; Evans T; Neubig RR; Jaffrey SR
Cell; 2014 Jan; 156(3):563-76. PubMed ID: 24440334
[TBL] [Abstract][Full Text] [Related]
8. LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration.
Hu Q; Guo C; Li Y; Aronow BJ; Zhang J
Mol Cell Biol; 2011 Aug; 31(16):3223-40. PubMed ID: 21670154
[TBL] [Abstract][Full Text] [Related]
9. RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling.
Hayashi K; Watanabe B; Nakagawa Y; Minami S; Morita T
PLoS One; 2014; 9(2):e89016. PubMed ID: 24558465
[TBL] [Abstract][Full Text] [Related]
10. Rho signaling inhibitor, CCG-1423, inhibits axonal elongation and dendritic complexity of rat cortical neurons.
Kikuchi K; Shiota J; Yamada T; Ishikawa M; Ihara D; Fukuchi M; Tsuda M; Tabuchi A
Biochem Biophys Res Commun; 2017 Oct; 492(3):474-479. PubMed ID: 28830810
[TBL] [Abstract][Full Text] [Related]
11. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
12. Targeting MRTF/SRF in CAP2-dependent dilated cardiomyopathy delays disease onset.
Xiong Y; Bedi K; Berritt S; Attipoe BK; Brooks TG; Wang K; Margulies KB; Field J
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30762586
[TBL] [Abstract][Full Text] [Related]
13. Does p49/STRAP, a SRF-binding protein (SRFBP1), modulate cardiac mitochondrial function in aging?
Zhang X; Williams ED; Azhar G; Rogers SC; Wei JY
Exp Gerontol; 2016 Sep; 82():150-9. PubMed ID: 27337995
[TBL] [Abstract][Full Text] [Related]
14. Rho Kinase Regulates Aortic Vascular Smooth Muscle Cell Stiffness Via Actin/SRF/Myocardin in Hypertension.
Zhou N; Lee JJ; Stoll S; Ma B; Costa KD; Qiu H
Cell Physiol Biochem; 2017; 44(2):701-715. PubMed ID: 29169155
[TBL] [Abstract][Full Text] [Related]
15. Control of myofibroblast differentiation by microtubule dynamics through a regulated localization of mDia2.
Sandbo N; Ngam C; Torr E; Kregel S; Kach J; Dulin N
J Biol Chem; 2013 May; 288(22):15466-73. PubMed ID: 23580645
[TBL] [Abstract][Full Text] [Related]
16. CCG-1423-derived compounds reduce global RNA synthesis and inhibit transcriptional responses.
Prajapati B; Sokolova M; Sidorenko E; Kyriacou M; Kyheröinen S; Vihervaara A; Vartiainen MK
J Cell Sci; 2024 Jun; ():. PubMed ID: 38841882
[TBL] [Abstract][Full Text] [Related]
17. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis.
Medjkane S; Perez-Sanchez C; Gaggioli C; Sahai E; Treisman R
Nat Cell Biol; 2009 Mar; 11(3):257-68. PubMed ID: 19198601
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Inhibition of Rho/MKL/SRF Transcription in Prostate Cancer Cells: Modulation of Cell Cycle, ER Stress, and Metastasis Gene Networks.
Evelyn CR; Lisabeth EM; Wade SM; Haak AJ; Johnson CN; Lawlor ER; Neubig RR
Microarrays (Basel); 2016 May; 5(2):. PubMed ID: 27600078
[TBL] [Abstract][Full Text] [Related]
19. Interaction of serum response factor (SRF) with the Elk-1 B box inhibits RhoA-actin signaling to SRF and potentiates transcriptional activation by Elk-1.
Murai K; Treisman R
Mol Cell Biol; 2002 Oct; 22(20):7083-92. PubMed ID: 12242287
[TBL] [Abstract][Full Text] [Related]
20. The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass.
Uittenbogaard M; Baxter KK; Chiaramello A
ASN Neuro; 2010 May; 2(2):e00034. PubMed ID: 20517466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
